XLH patient registry for people with X-linked hypophosphatemia
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This registry collects information about people diagnosed with X-linked hypophosphatemia (XLH). It helps researchers better understand the condition and may support future studies by tracking patients over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) are age 0 or older at the time of enrollment
- Your doctor believes you have XLH based on symptoms, scans, lab results, or genetic testing
- You are not taking part in a clinical trial that tests a treatment right now
- You (or your legal representative) can understand and agree to the study after it’s explained
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called KK8123 for adults with X-linked hypophosphatemia (XLH), a rare condition that causes low phosphate levels and can lead to bone problems. The goal is to see if it helps improve phosphate levels in the body.
This program provides access to a medication called burosumab (Crysvita) for people with a rare genetic condition called X-linked hypophosphatemia (XLH), which causes weak bones and low phosphate levels. It is designed for those who cannot get the drug through normal channels or other clinical trials.
This trial is a registry that collects information about people with hypophosphatasia to help researchers understand the condition better. It may help future studies, but it’s not a treatment trial.
This study follows people who already have hypophosphatasia (HPP) to better understand how the condition changes over time. It may help doctors recognize patterns and improve care, even if you are not receiving a new treatment.
This early study looks at how the body’s handling of phosphate may affect aging and bone health. It is meant for people with certain rare genetic conditions that change phosphate levels, to better understand their biology and responses to study tests.
This is a long-term registry study for people with a confirmed diagnosis of paroxysmal nocturnal hemoglobinuria (PNH). It simply collects information over time to better understand the condition and how it's managed. There is no experimental treatment involved.
Hear when a new X-linked Hypophosphatemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.